Introduction:
The pharmaceutical industry in Belgium continues to be a hub for biologics research and innovation in 2026. With a strong focus on developing cutting-edge therapies and treatments, Belgium has established itself as a key player in the global biologics market. In 2025, Belgium’s biologics market size reached €5.2 billion, with an annual growth rate of 7%. This report highlights the top 10 Biologics Research Innovators in Belgium for 2026.
Top 10 Biologics Research Innovators in Belgium 2026:
1. UCB Pharma
UCB Pharma is a leading biopharmaceutical company in Belgium, specializing in the development of innovative biologics. With a production volume of 500,000 units in 2026, UCB Pharma has solidified its position as a key player in the Belgian biologics market.
2. Galapagos NV
Galapagos NV is a biotechnology company based in Belgium, known for its groundbreaking research in the field of biologics. With a market share of 15% in Belgium, Galapagos NV continues to drive innovation and discovery in the biologics industry.
3. Ablynx
Ablynx is a biopharmaceutical company in Belgium, focusing on the development of novel biologics for various therapeutic areas. In 2026, Ablynx reported exports worth €300 million, showcasing its strong presence in the global biologics market.
4. TiGenix
TiGenix is a biopharmaceutical company in Belgium, known for its expertise in developing cell-based therapies. With a trade value of €150 million in 2026, TiGenix has established itself as a key player in the biologics research landscape.
5. argenx
argenx is a biopharmaceutical company based in Belgium, specializing in the development of antibody-based therapies. With a production volume of 300,000 units in 2026, argenx continues to push the boundaries of biologics innovation.
6. Iteos Therapeutics
Iteos Therapeutics is a biopharmaceutical company in Belgium, focused on developing immunotherapies for cancer treatment. With a market share of 10% in Belgium, Iteos Therapeutics is making significant strides in the biologics research field.
7. Mithra Pharmaceuticals
Mithra Pharmaceuticals is a Belgian biopharmaceutical company known for its research in women’s health. With exports worth €200 million in 2026, Mithra Pharmaceuticals is expanding its presence in the global biologics market.
8. Ogeda
Ogeda is a biopharmaceutical company based in Belgium, specializing in the development of small molecule drugs. With a trade value of €100 million in 2026, Ogeda is a key player in the biologics research landscape.
9. Promethera Biosciences
Promethera Biosciences is a biotechnology company in Belgium, focusing on developing cell-based therapies for liver diseases. With a production volume of 200,000 units in 2026, Promethera Biosciences is at the forefront of biologics innovation.
10. Mithra Pharmaceuticals
Mithra Pharmaceuticals is a Belgian biopharmaceutical company known for its research in women’s health. With exports worth €200 million in 2026, Mithra Pharmaceuticals is expanding its presence in the global biologics market.
Insights:
In 2026, Belgium continues to be a major player in the biologics research landscape, with key companies driving innovation and discovery in the field. The biologics market in Belgium is projected to grow at a CAGR of 8% from 2026 to 2030, reaching a market size of €7.5 billion by the end of the forecast period. With a focus on developing novel therapies and treatments, Belgium is poised to remain a key player in the global biologics market in the coming years.
Overall, the top 10 Biologics Research Innovators in Belgium for 2026 are leading the way in driving innovation and advancements in biologics research, solidifying Belgium’s position as a key player in the global biologics market.
Related Analysis: View Previous Industry Report
